Actinogen Medical Limited (ASX:ACW) Annual Report 2022



The latest annual report of Actinogen Medical Limited (ACW) was published on 30 Jun 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - ACW Annual Results

Amounts in AUD

Total Revenue
3.64M
Gross Profit
3.64M
EBIT
-9.53M
Net Tangible Assets
19.02M
Net Income
-9.5M
Capital Expenditures
-2.94k

ACW Income Statement 2022 Annual Report

As per the latest Income Statement of ACW, the Net revenue increased by $1.66M (83%) compared to the previous period. The operating income in 2022 decreased by $-5.61M (-143%). The net income as per the annual report was -9.5M which decreased by $-5.58M (-143%) compared to previous year.

Income Statement Report (2022/2021)

2022 2021
Total Revenue 3.64M 1.98M
Gross Profit 3.64M 1.98M
Operating Income -9.53M -3.92M
Income Before Tax -9.5M -3.92M
Net Income -9.5M -3.92M

Balance Sheet - ACW 2022 Annual Report

Read further: ACW Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Actinogen Medical Limited showed the company increased the cash on balance sheet by $2.91M (22%). The Net tangible assets of ACW on the balance sheet were at 19.02M which is $4.59M (32%) more than previous annual report. The total stockholder equity also increased by $4.28M (25%) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

2022 2021
Cash 16.37M 13.46M
Total Assets 23.31M 18.38M
Long Term Debt - -
Total Liabilities 1.57M 920.32k
Total Shareholder Equity 21.74M 17.46M
Net Tangible Assets 19.02M 14.42M

Cash Flow Statement - ACW 2022 Annual Report

The 2022 annual cash flow statement of Actinogen Medical Limited showed that the net income decreased by $-5.58M (-143%) compared to previous reporting period. Also the capital expenditure of ACW increased by $3251 (53%).

As of 2022, the total cash from investing activities was -2.94k and total cash from financing activities was 12.42M.

Cash Flow Statement Report (2022/2021)

2022 2021
Net Income -9.5M -3.92M
Capital Expenditures -2.94k -6.19k
Dividends Paid - -
Total Cash From From Investing Activities -2.94k -6.19k
Total Cash From From Financing Activities 12.42M 10.11M

Actinogen Medical Limited Annual Report History

Income Statement

Income Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Total Revenue 3.64M 1.98M 3.52M 4.86M
Cost Of Revenue - - - -
Gross Profit 3.64M 1.98M 3.52M 4.86M
Research Development 8.21M 2.41M 5.54M 10.9M
Selling General Administrative 3.27M 2.82M 2.77M 3.09M
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses 13.17M 5.9M 8.91M 14.47M
Operating Income -9.53M -3.92M -5.4M -9.61M
Total Other Income Expense Net 35.99k 4.77k 65.17k -280.34k
Ebit -9.53M -3.92M -5.4M -9.61M
Interest Expense -18.48k -22.32k -28.88k -7.99k
Income Before Tax -9.5M -3.92M -5.33M -9.89M
Income Tax Expense - - - -
Minority Interest - - - -
Net Income From Continuing Ops -9.5M -3.92M -5.33M -9.89M
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income -9.5M -3.92M -5.33M -9.89M
Net Income Applicable To Common Shares -9.5M -3.92M -5.33M -9.89M

Balance Sheet Statement

Balance Sheet Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Cash 16.37M 13.46M 5.04M 7.64M
Net Receivables 3.94M 1.54M 2.66M 4.83M
Total Current Assets 20.42M 15.09M 8.16M 12.53M
Property Plant Equipment 168.97k 253.96k 391.04k -
Intangible Assets 2.72M 3.03M 3.35M 3.66M
Total Assets 23.31M 18.38M 11.94M 16.22M
Accounts Payable 898.74k 392.19k 46.84k 282.82k
Total Current Liabilities 1.48M 755.05k 743.82k 557.39k
Total Liab 1.57M 920.32k 1.05M 557.39k
Common Stock 81.88M 64.16M 51.32M 51.44M
Retained Earnings -57.94M -48.44M -44.53M -39.2M
Treasury Stock -2.2M 1.74M 4.1M 3.42M
Other Stockholder Equity -2.2M 1.74M 4.1M 3.42M
Total Stockholder Equity 21.74M 17.46M 10.89M 15.66M
Net Tangible Assets 19.02M 14.42M 7.54M 12M
Long Term Debt - - - -

Cash Flow Statement

Cash Flow Statement history of Actinogen Medical Limited (ASX:ACW)

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Net Income -9.5M -3.92M -5.33M -9.89M
Depreciation 400.67k 386.69k 412.93k 353.5k
Change To Netincome 1.27M 289.28k 194.49k 604.85k
Change To Account Receivables -2.41M 1.49M 1.77M -1.36M
Change To Liabilities 688.81k 110.3k 75.7k -215.65k
Change To Operating Activities 28.52k -84.22k 24.7k 4.79k
Total Cash From Operating Activities -9.52M -1.72M -2.86M -10.5M
Capital Expenditures -2.94k -6.19k -22.76k -22.76k
Total Cashflows From Investing Activities -2.94k -6.19k -22.76k 71.77k
Net Borrowings -71.17k -84.1k -77.74k -77.74k
Other Cashflows From Financing Activities -831.29k -715.87k -715.87k -317.25k
Total Cash From Financing Activities 12.42M 10.11M 282.26k 8.17M
Effect Of Exchange Rate 13.39k 13.39k 13.39k 13.39k
Change In Cash 2.95M 8.38M -2.6M -2.26M
Issuance Of Stock 13.32M 10.91M 360k 8.48M
Dividends Paid - - - -